Phosphoethanolamine addition to the Heptose I of the Lipopolysaccharide modifies the inner core structure and has an impact on the binding of Polymyxin B to the Escherichia coli outer membrane

Archives of Biochemistry and Biophysics

Volumn 620, Issue , 2017, Pages 28-34

  Salazar, Javier ^a   Alarcón, Mackarenna ^a   Huerta, Jaime ^a   Navarro, Belén ^a   Aguayo, Daniel ^a,b  

^a UNIVERSIDAD ANDRÉS BELLO   (Chile)

^b Centro Interdisciplinario de Neurociencias de Valparaíso   (Chile)

Author keywords

Lipopolysaccharide; Phosphoethanolamine; Polymyxin

Indexed keywords

1 NAPHTHYLAMINE; BACTERIUM LIPOPOLYSACCHARIDE; HEPTOSE; NOVOBIOCIN; PHOSPHOETHANOLAMINE; POLYMYXIN B; EPTB PROTEIN, E COLI; EPTC PROTEIN, E COLI; ESCHERICHIA COLI PROTEIN; ETHANOLAMINE DERIVATIVE; LIPID A; MEMBRANE PROTEIN; PHOSPHOTRANSFERASE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL OUTER MEMBRANE; CONFORMATION; CONTROLLED STUDY; ESCHERICHIA COLI K 12; GENE MUTATION; HYDROGEN BOND; IN VIVO STUDY; MEMBRANE PERMEABILITY; MEMBRANE VESICLE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DYNAMICS; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; THEORETICAL MODEL; ZETA POTENTIAL; CELL MEMBRANE; CHEMISTRY; ESCHERICHIA COLI; GENE DELETION; GENETICS; METABOLISM;

CELL MEMBRANE; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; ETHANOLAMINES; GENE DELETION; HEPTOSES; LIPID A; MEMBRANE PROTEINS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMYXIN B;

EID: 85016149623     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2017.03.008     Document Type: Article

References (38)

1. [1] Whitfield, C., Trent, M.S., Biosynthesis and export of bacterial Lipopolysaccharides. Annu. Rev. Biochem. 83 (2014), 99–128, 10.1146/annurev-biochem-060713-035600.
2. [2] Kawasaki, K., Endotoxin modifications in the bacterial outer membrane: Lipopolysaccharide lipid a remodeling in Salmonella Typhimurium. Immunol. Endocr. Metab. Agents Med. Chem. 9 (2009), 224–233, 10.2174/187152209790773011.
3. [3] Kanazawa, K., Sato, Y., Ohki, K., Okimura, K., Uchida, Y., Shindo, M., Sakura, N., Contribution of each amino acid residue in polymyxin B(3) to antimicrobial and lipopolysaccharide binding activity. Chem. Pharm. Bull. 57 (2009), 240–244, 10.1248/cpb.57.240 (Tokyo).
4. [4] Yu, Z., Qin, W., Lin, J., Fang, S., Qiu, J., Antibacterial mechanisms of polymyxin and bacterial resistance. Biomed. Res. Int. 2015 (2015), 1–11, 10.1155/2015/679109.
5. [5] Trimble, M.J., Mlynárčik, P., Kolář, M., Hancock, R.E.W., Polymyxin: alternative mechanisms of action and resistance. Cold Spring Harb. Perspect. Med., 6, 2016, a025288, 10.1101/cshperspect.a025288.
6. [6] Anaya-López, J.L., López-Meza, J.E., Ochoa-Zarzosa, A., Bacterial resistance to cationic antimicrobial peptides. Crit. Rev. Microbiol. 39 (2013), 180–195, 10.3109/1040841X.2012.699025.
7. [7] Liu, Y.-Y., Wang, Y., Walsh, T.R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., Yu, L.-F., Gu, D., Ren, H., Chen, X., Lv, L., He, D., Zhou, H., Liang, Z., Liu, J.-H., Shen, J., Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16 (2016), 161–168, 10.1016/S1473-3099(15)00424-7.
8. [8] Klein, G., Muller-Loennies, S., Lindner, B., Kobylak, N., Brade, H., Raina, S., Molecular and structural basis of inner core Lipopolysaccharide alterations in Escherichia coli: incorporation of glucuronic acid and phosphoethanolamine in the Heptose region. J. Biol. Chem. 288 (2013), 8111–8127, 10.1074/jbc.M112.445981.
9. [9] Tamayo, R., Choudhury, B., Septer, A., Merighi, M., Carlson, R., Gunn, J.S., Identification of cptA, a PmrA-regulated Locus required for phosphoethanolamine modification of the Salmonella enterica Serovar Typhimurium Lipopolysaccharide core. J. Bacteriol. 187 (2005), 3391–3399, 10.1128/JB.187.10.3391-3399.2005.
10. [10] Wiegand, I., Hilpert, K., Hancock, R.E.W., Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3 (2008), 163–175, 10.1038/nprot.2007.521.
11. [11] Helander, I.M., Mattila-Sandholm, T., Fluorometric assessment of Gram-negative bacterial permeabilization. J. Appl. Microbiol. 88 (2000), 213–219, 10.1046/j.1365-2672.2000.00971.x.
12. [12] Inka, B., Glycobiology Protocols. first ed., 2006, Humana Press, New Jersey, 10.1385/1597451673.
13. [13] Domingues, M.M., Inacio, R.G., Raimundo, J.M., Martins, M., Castanho, M. a R.B., Santos, N.C., Biophysical characterization of polymyxin B interaction with LPS aggregates and membrane model systems. Biopolymers 98 (2012), 338–344, 10.1002/bip.22095.
14. [14] Lee, J., Cheng, X., Swails, J.M., Yeom, M.S., Eastman, P.K., Lemkul, J.A., Wei, S., Buckner, J., Jeong, J.C., Qi, Y., Jo, S., Pande, V.S., Case, D.A., Brooks, C.L., MacKerell, A.D., Klauda, J.B., Im, W., CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 12 (2016), 405–413, 10.1021/acs.jctc.5b00935.
15. [15] Venkataraman, M., Sasisekharan, R., Raman, R., Glycoinformatics. 2015, Springer New York, New York, NY, 10.1007/978-1-4939-2343-4.
16. [16] Klauda, J.B., Venable, R.M., Freites, J.A., O'Connor, J.W., Tobias, D.J., Mondragon-Ramirez, C., Vorobyov, I., MacKerell, A.D., Pastor, R.W., Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J. Phys. Chem. B 114 (2010), 7830–7843, 10.1021/jp101759q.
17. [17] Guvench, O., Greene, S.N., Kamath, G., Brady, J.W., Venable, R.M., Pastor, R.W., Mackerell, A.D., Additive empirical force field for hexopyranose monosaccharides. J. Comput. Chem. 29 (2008), 2543–2564, 10.1002/jcc.21004.
18. [18] Guvench, O., Hatcher, E., Venable, R.M., Pastor, R.W., MacKerell, A.D., CHARMM additive all-atom force field for glycosidic Linkages between Hexopyranoses. J. Chem. Theory Comput. 5 (2009), 2353–2370, 10.1021/ct900242e.
19. [19] Guvench, O., Mallajosyula, S.S., Raman, E.P., Hatcher, E., Vanommeslaeghe, K., Foster, T.J., Jamison, F.W., MacKerell, A.D., CHARMM additive all-atom force field for carbohydrate derivatives and its utility in polysaccharide and carbohydrate–protein modeling. J. Chem. Theory Comput. 7 (2011), 3162–3180, 10.1021/ct200328p.
20. [20] Aguayo, D., González-Nilo, F.D., Chipot, C., Insight into the properties of cardiolipin containing bilayers from molecular dynamics simulations, using a hybrid all-atom/united-atom force field. J. Chem. Theory Comput. 8 (2012), 1765–1773, 10.1021/ct200849k.
21. [21] Phillips, J.C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R.D., Kalé, L., Schulten, K., Scalable molecular dynamics with NAMD. J. Comput. Chem. 26 (2005), 1781–1802, 10.1002/jcc.20289.
22. [22] Kim, S., Patel, D.S., Park, S., Slusky, J., Klauda, J.B., Widmalm, G., Im, W., Bilayer properties of lipid a from various gram-negative bacteria. Biophys. J. 111 (2016), 1750–1760, 10.1016/j.bpj.2016.09.001.
23. [23] Raetz, C.R.H., Reynolds, C.M., Trent, M.S., Bishop, R.E., Lipid A modification systems in gram-negative bacteria. Annu. Rev. Biochem. 76 (2007), 295–329, 10.1146/annurev.biochem.76.010307.145803.
24. [24] Klein, G., Raina, S., Regulated control of the assembly and diversity of lps by noncoding sRNAs. Biomed. Res. Int., 2015, 2015, 10.1155/2015/153561.
25. [25] Yethon, J.A., Heinrichs, D.E., Monteiro, M.A., Perry, M.B., Whitfield, C., Involvement of waaY, waaQ, and waaP in the modification of Escherichia coli Lipopolysaccharide and their role in the formation of a stable outer membrane *., 273, 1998, 26310–26316.
26. [26] Velkov, T., Roberts, K.D., Nation, R.L., Wang, J., Thompson, P.E., Li, J., Teaching “Old” polymyxins new tricks: new-generation Lipopeptides targeting gram-negative “Superbugs”. ACS Chem. Biol. 9 (2014), 1172–1177, 10.1021/cb500080r.
27. [27] Olaitan, A.O., Morand, S., Rolain, J.-M., Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front. Microbiol. 5 (2014), 1–18, 10.3389/fmicb.2014.00643.
28. [28] Helander, I.M., Mattila-Sandholm, T., Fluorometric assessment of Gram-negative bacterial permeabilization. J. Appl. Microbiol. 88 (2000), 213–219, 10.1046/j.1365-2672.2000.00971.x.
29. [29] Humphries, R.M., Susceptibility testing of the polymyxins: where are we now?. Pharmacotherapy 35 (2015), 22–27, 10.1002/phar.1505.
30. [30] Knirel, Y.A., Valvano, M.A., Bacterial Lipopolysaccharides: structure, chemical synthesis. Biogenesis and Interaction with Host Cells, first ed., 2011, Springer Vienna, Vienna, 10.1007/978-3-7091-0733-1.
31. [31] Jeannot, K., Bolard, A., Plésiat, P., Resistance to polymyxins in Gram-negative organisms. Int. J. Antimicrob. Agents, 2017, 10.1016/j.ijantimicag.2016.11.029 Available online 3 February 2017, ISSN 0924-8579.
32. [32] Aurell, C. a, Wistrom, A.O., Critical aggregation concentrations of gram-negative bacterial Lipopolysaccharides (LPS). Biochem. Biophys. Res. Commun. 253 (1998), 119–123, 10.1006/bbrc.1998.9773.
33. [33] Deris, Z.Z., Swarbrick, J.D., Roberts, K.D., Azad, M.A.K., Akter, J., Horne, A.S., Nation, R.L., Rogers, K.L., Thompson, P.E., Velkov, T., Li, J., Probing the penetration of antimicrobial polymyxin Lipopeptides into gram-negative bacteria. Bioconjug. Chem. 25 (2014), 750–760, 10.1021/bc500094d.
34. [34] Halder, S., Yadav, K.K., Sarkar, R., Mukherjee, S., Saha, P., Haldar, S., Karmakar, S., Sen, T., Alteration of Zeta potential and membrane permeability in bacteria: a study with cationic agents. Springerplus, 4, 2015, 672, 10.1186/s40064-015-1476-7.
35. [35] Berglund, N.A., Piggot, T.J., Jefferies, D., Sessions, R.B., Bond, P.J., Khalid, S., Interaction of the antimicrobial peptide polymyxin B1 with both membranes of E. coli: a molecular dynamics study. PLOS Comput. Biol., 11, 2015, e1004180, 10.1371/journal.pcbi.1004180.
36. [36] Wu, E.L., Engström, O., Jo, S., Stuhlsatz, D., Yeom, M.S., Klauda, J.B., Widmalm, G., Im, W., Molecular dynamics and NMR spectroscopy studies of E. coli Lipopolysaccharide structure and dynamics. Biophys. J. 105 (2013), 1444–1455, 10.1016/j.bpj.2013.08.002.
37. [37] Frirdich, E., Whitfield, C., Review: Lipopolysaccharide inner core oligosaccharide structure and outer membrane stability in human pathogens belonging to the Enterobacteriaceae. J. Endotoxin Res. 11 (2005), 133–144, 10.1177/09680519050110030201.
38. [38] Pérez, J.M., McGarry, M. a, Marolda, C.L., Valvano, M. a, Functional analysis of the large periplasmic loop of the Escherichia coli K-12 WaaL O-antigen ligase. Mol. Microbiol. 70 (2008), 1424–1440, 10.1111/j.1365-2958.2008.06490.x.